Microneedle Drug Delivery Systems Market Segmentation:
Material Segment Analysis
The metal segment is anticipated to garner the largest revenue share of 44% in the microneedle drug delivery systems market over the assessed timeline. The leadership of this segment is attributable to the rising number of cosmetic procedures performed with metal microneedles array to treat acne, stretch marks, hair loss, and more. In addition, this subtype is also widely used for treating various malignancies. For instance, an NLM study from December 2022 mentioned several examples of the utility of metallic microneedles (MNs). One of them was 1100 μm long and was used in treating breast cancer, demonstrating 5 times higher tumor suppression. Similarly, it mentioned the utilization of metallic MN arrays in ovarian and skin cancer, showcasing tumor suppression within 5 minutes and 90.0% drug delivery efficacy.
Type Segment Analysis
In terms of type, the hollow segment is poised to gain notable traction in the microneedle drug delivery systems market by 2035. The most important driving factor in this segment is the high compliance with patients, clinicians, healthcare administrators, and regulators, owing to its long-acting and safe characteristics. Ongoing R&D initiatives and rising demand for alternatives with better safety profiles in comparison to traditional hypodermic injections are making this type of MN more desirable. In addition, the introduction of 3D printing is mitigating the limitations in the fabrication of these solutions, solidifying their leadership in large-dose administration and molecular-weight substances.
Our in-depth analysis of the global microneedle drug delivery systems market includes the following segments:
|
Type |
|
|
Material |
|
|
Application |
|
|
End user |
|
